Financials

  • Market Capitalization 645.92 M
  • Employee 2
  • Founded 2024
  • CEO N/A
  • Website N/A
  • Headquarter New York, United States
  • FIGI N/A
  • Industry Shell Companies
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
66
Price to sales ratio
-1 061.96

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2344
UMAC
Unusual Machines, Inc. Common Stock
23.95 USD-8.94%-9.21%+31.23%+83.11%1.20 B USD
2460
TRON
Tron Inc. - Common Stock
2.08 USD-2.80%+2.97%+42.47%-51.40%986.71 M USD
2805
EVAC
EQV Ventures Acquisition Corp. II Class A Ordinary Shares
10.29 USD+0.10%+0.19%0.00%+3.63%601.43 M USD
2807
BCSS
Bain Capital GSS Investment Corp. Class A Ordinary Shares
10.28 USD0.00%0.00%+0.59%+2.09%600.35 M USD

Frequently asked questions about Drugs Made In America Acquisition II Corp. Ordinary Shares

What is the Drugs Made In America Acquisition II Corp. Ordinary Shares stock price today?

The current price of Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) is 10.14. Over the past 24 hours, the stock has changed by +0.10%. Follow the DMII chart for real-time price dynamics.

What is the stock ticker of Drugs Made In America Acquisition II Corp. Ordinary Shares?

Drugs Made In America Acquisition II Corp. Ordinary Shares trades under the ticker DMII. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Drugs Made In America Acquisition II Corp. Ordinary Shares stock going up?

DMII has changed by 0.00% over the last week, +0.30% over the last month, and +2.74% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Drugs Made In America Acquisition II Corp. Ordinary Shares?

Drugs Made In America Acquisition II Corp. Ordinary Shares currently has a market capitalization of 645.92 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Drugs Made In America Acquisition II Corp. Ordinary Shares earnings last quarter?

Last quarter, Drugs Made In America Acquisition II Corp. Ordinary Shares reported earnings of 0.07 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Drugs Made In America Acquisition II Corp. Ordinary Shares net income for the last quarter?

Drugs Made In America Acquisition II Corp. Ordinary Shares reported net income of 4.4 M for the last quarter. The previous quarter showed 4.34 M, which means net income changed by +1.35%.

How many employees does Drugs Made In America Acquisition II Corp. Ordinary Shares have?

As of the latest available data, Drugs Made In America Acquisition II Corp. Ordinary Shares has 2 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Drugs Made In America Acquisition II Corp. Ordinary Shares stock?

You can buy Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Drugs Made In America Acquisition II Corp. Ordinary Shares stock?

Investing in Drugs Made In America Acquisition II Corp. Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DMII chart and related analysis on metatrader.com as part of your research.